Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3300-3304

  Thomsen, Lindy L ^a   Scott, James M J ^a   Topley, Peter ^a   Knowles, Richard G ^a   Keerie, Amanda Jane ^a   Frend, Anthony J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER INHIBITION; CANCER THERAPY; COLON ADENOCARCINOMA; ENZYME INHIBITION; GENETIC ENGINEERING; HOST RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; SOLID TUMOR; TUMOR GROWTH;

ADENOCARCINOMA; AMIDINES; ANIMALS; ARGININE; BENZYLAMINES; COLONIC NEOPLASMS; ENZYME INHIBITORS; HEMATOPOIETIC STEM CELLS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NITRATES; NITRIC OXIDE SYNTHASE; NITRITES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030877443     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Knowles, R. G., and Moncada, S. Nitric oxide synthase in mammals. Biochem. J., 298: 249-258, 1994.
2. Moncada, S., Palmer, R. M. J., and Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43: 109-142, 1991.
3. Hibbs, J. B., Vavrin, Z., and Taintor, R. R. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol., 138: 550-565, 1987.
4. Stuehr, D. J., and Nathan, C. F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med., 169: 1543-1555, 1989.
5. Cui, S., Reichner, J. S., Mateo, R. B., and Albina, J. E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res., 5: 2462-2467, 1994.
6. Thomsen, L. L., Baguley, B. C., and Wilson, W. R. Nitric oxide: its production in host cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxamhenone-4-acetic acid. Cancer Chemother. Pharmacol., 31: 151-155, 1992.
7. Farais-Eisner, R., Sherman, M. P., Aeberhard, E., and Chaudhuri, G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA, 91: 9407-9411, 1994.
8. Thomsen, L. L., Lawton, F. G., Knowles, R. G., Beesley, J. E., Riveros-Moreno, V., and Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54: 1352-1354, 1994.
9. Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72: 41-44, 1995.
10. Cobbs, C. S., Brenman, J. E., Aldape, K. D., Bredt, D. S., and Israel, M. A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55: 727-730, 1995.
11. Jenkins, D. C, Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92: 4392-4396, 1995.
12. Garvey, E. P., Oplinger, J. A., Furfine, E. S., Kiff, R. J., Laszlo, F., Whittle, B. J. R., and Knowles, R. G. 1400W is a slow, tight-binding and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J. Biol. Chem., 272: 4959-4963, 1997.
13. Omerovic, I., and Thomsen, L. L. Differential expression of nitric oxide synthase in five murine tumors. Proc. Am. Assoc. Cancer Res., 37: 493, 1996.
14. Workman, P., Balmain, A., Hickman, J. A., McNally, N. J., Mitchison, N. A., Pierrepoint, C. G., Rowlatt, C, Stephens, T. C., and Wallace, J. UKCCR guidelines for the welfare of animals in experimental neoplasia. Br. J. Cancer, 58: 109-113, 1988.
15. Thomsen, L. L., Ching, L-M., Zhaung, L., Gavin, J. B., and Baguley, B. C. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice. Cancer Res., 57: 77-81, 1991.
16. The Wellcome Foundation Limited. International Patent Application Number WO96/ 19440, 1996.
17. The Wellcome Foundation Limited. International Patent Application Number WO95/ 34534, 1995.
18. Frauser, A. A., and Messner, H. A. Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood, 52: 1243-1248, 1978.
19. Edwards, P., Cendan, J. C., Topping, D. B., Moldawer, L. L., Mackay, S., Copeland, E. M., and Lind, D. S. Tumor cell nitric oxide inhibits cell growth in vitro but stimulates tumorigenesis and experimental lung metastasis in vivo. J. Surg. Res., 63: 49-52, 1996.
20. Rees, D. D., Palmer, R. M. J., Schulz, R., Hodson, H. F., and Moncada, S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101: 746-752, 1990.
21. Andrade, S. P., Hart, I. R., and Piper, P. J. Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br. J. Pharmacol., 107: 1092-1095, 1992.
22. Wood, P. J., Stratford, I. J., Adams, G. E., Szabo, C., Thiemermann, C., and Vane, J. R. Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability. Biochem. Biophys. Res. Commun., 192: 505-510, 1993.
23. Peterson, H. I. Modification of tumour blood flow: a review. Int. J. Radiat. Biol., 60: 201-210, 1991.
24. Veszelovszky, E., Thomsen, L. L., Zhaung, L., and Baguley, B. C. Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: relationship between plasma nitrate elevation and the induction of tumour necrosis. Eur. J. Cancer, 29A: 404-408, 1993.
25. Xie, K., Huang, S., Dong, Z., Juang, S-H., Gutman, M., Xie, Q-W., Nathan, C., and Fidler, I. J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med., 181: 1333-1343, 1995.